Tumor hypoxia (lack of oxygen) is a common cause of resistance to cancer therapy. Under hypoxic conditions, cancer cells become more invasive, aggressive and proliferative, leading to treatment...
Employees: 1-10
Founded date: 2018
Investors 2
| Date | Name | Website |
| 01.06.2021 | Creative D... | creativede... |
| - | Fight Agai... | facit.ca |
Mentions in press and media 2
| Date | Title | Description |
| 17.05.2021 | Today in funding: Nanology Labs, Covalent, Audioptics Medical | Three Canadian startups have recently announced fresh funding rounds to fuel their growth. Here’s the latest on who raised, how much, from whom, and what they’ll be putting the new funds toward. Nanology Labs closes $3 million seed round To... |
| 09.04.2019 | Nanology Labs receives investment from oncology research fund | Nanology Labs, a pharmaceutical startup based out of the University of Toronto, has received an investment from the FACIT Prospects Oncology Fund, which was designed to advance Ontario’s cancer research innovations by supporting proof-of-co... |